Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
about
Neuroprotective activities of CEP-1347 in models of neuroAIDS.In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementiaNeuropsychiatric manifestations of HIV infection and AIDSGlutamate metabolism and HIV-associated neurocognitive disorders.Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitisMicroglia in human immunodeficiency virus-associated neurodegeneration.Matrix metalloproteinases and neuroinflammation in multiple sclerosis.Regulation of microglia - potential new drug targets in the CNS.PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.Rodent models for HIV-associated neurocognitive disorders.Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitisHuman immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.Opiate drug use and the pathophysiology of neuroAIDS.Battle of animal models.PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.Separate sequences in a murine retroviral envelope protein mediate neuropathogenesis by complementary mechanisms with differing requirements for tumor necrosis factor alpha.CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.Mechanism of blood-retinal barrier breakdown induced by HIV-1 (Review).Platelet-activating factor attenuation of long-term potentiation in rat hippocampal slices via protein tyrosine kinase signaling.Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection.Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.HIV-1 infection: new treatment paradigms.Brain Damage and Alcohol Dependence: How One May Influence the Other
P2860
Q33587971-00E10854-4212-48F6-8CA1-34931D87190BQ33749579-2F98FAC3-51D5-4527-8A3E-5F906A1AA09EQ33843573-44D44F2F-CE05-49EB-A047-59AF135103ACQ33868874-235E8A61-3130-4465-A90A-8CEBCBC08E24Q33903612-6FCA0C40-3125-400D-910F-B7BE53F02261Q34761828-BEDD0FD5-4414-425F-8381-85E60AF088ECQ34963796-A95FEA97-B684-41F2-BEEE-B0D4024C0BBFQ35017633-461FAAEF-7F8E-4225-A446-19C17481073BQ35050412-1EF5A520-BAC2-4F0C-8513-2ED0A8EEFF98Q35497152-0582B784-8475-430C-AC10-8C6F380BCA00Q35803957-52EADD7A-C9B6-4C62-A344-DFACED93C0A8Q35968510-1669B36C-78A5-499B-B578-479FA2CDBBEAQ36148402-570839F8-31D7-40CA-8998-4F998F429908Q36201412-0755D634-8213-4AA7-A7BD-5570CD83A14FQ37015533-C1102CF5-EF73-480B-A33C-AC900BBBB9D1Q37159206-BED62BA8-BB89-4E0B-B661-275A245BCFB4Q37375561-E5B34276-39CB-40DF-B504-59E1ED028DACQ37596496-3C47DDBD-F37E-4CB1-AFBC-FF9D049D0CF7Q37600700-52CD129A-3E13-49EB-AE37-01E7DFCBAB84Q37652087-9CF72385-204E-443E-B344-E79326F0CF22Q38512226-130F818D-A299-480C-8C9C-68F9B992E7BBQ39404652-6B0CB486-F926-4E32-9C66-63EDFD3B26B9Q39756120-3C1F3060-E94D-4F59-A645-C3636D5452C7Q53783170-F7D888E9-87F7-4C60-89B2-F5CDC55D70B5Q58295123-AEA8A03A-8450-474E-A08D-97E1CDD58A20
P2860
Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
name
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@ast
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@en
type
label
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@ast
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@en
prefLabel
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@ast
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@en
P2093
P1476
Reduction in glial immunity an ...... mice with HIV-1 encephalitis.
@en
P2093
Gendelman HE
Persidsky Y
Rasmussen J
P356
10.1016/S0165-5728(00)00454-9
P577
2001-03-01T00:00:00Z